Literature DB >> 30036596

Endogenous bradykinin and B1-B5 during angiotensin-converting enzyme inhibitor-associated angioedema.

Scott A Hubers1, Kevin Kohm1, Shouzuo Wei1, Chang Yu2, Hui Nian2, Ryan Grabert3, Daniel J Sexton3, Nancy J Brown4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30036596      PMCID： PMC6226317          DOI： 10.1016/j.jaci.2018.06.037

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

1.  Bradykinin-mediated angioedema.

Authors:  Juerg Nussberger; Massimo Cugno; Marco Cicardi
Journal:  N Engl J Med       Date:  2002-08-22       Impact factor: 91.245

2.  Quantification of BK1-5, the stable bradykinin plasma metabolite in humans, by a highly accurate liquid-chromatographic tandem mass spectrometric assay.

Authors:  L J Murphey; D L Hachey; D E Vaughan; N J Brown; J D Morrow
Journal:  Anal Biochem       Date:  2001-05-01       Impact factor: 3.365

3.  A randomized trial of icatibant in ACE-inhibitor-induced angioedema.

Authors:  Murat Baş; Jens Greve; Klaus Stelter; Miriam Havel; Ulrich Strassen; Nicole Rotter; Johannes Veit; Beate Schossow; Alexander Hapfelmeier; Victoria Kehl; Georg Kojda; Thomas K Hoffmann
Journal:  N Engl J Med       Date:  2015-01-29       Impact factor: 91.245

4.  Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.

Authors:  Marco Cicardi; Aleena Banerji; Francisco Bracho; Alejandro Malbrán; Bernd Rosenkranz; Marc Riedl; Konrad Bork; William Lumry; Werner Aberer; Henning Bier; Murat Bas; Jens Greve; Thomas K Hoffmann; Henriette Farkas; Avner Reshef; Bruce Ritchie; William Yang; Jürgen Grabbe; Shmuel Kivity; Wolfhart Kreuz; Robyn J Levy; Thomas Luger; Krystyna Obtulowicz; Peter Schmid-Grendelmeier; Christian Bull; Brigita Sitkauskiene; William B Smith; Elias Toubi; Sonja Werner; Suresh Anné; Janne Björkander; Laurence Bouillet; Enrico Cillari; David Hurewitz; Kraig W Jacobson; Constance H Katelaris; Marcus Maurer; Hans Merk; Jonathan A Bernstein; Conleth Feighery; Bernard Floccard; Gerald Gleich; Jacques Hébert; Martin Kaatz; Paul Keith; Charles H Kirkpatrick; David Langton; Ludovic Martin; Christiane Pichler; David Resnick; Duane Wombolt; Diego S Fernández Romero; Andrea Zanichelli; Francesco Arcoleo; Jochen Knolle; Irina Kravec; Liying Dong; Jens Zimmermann; Kimberly Rosen; Wing-Tze Fan
Journal:  N Engl J Med       Date:  2010-08-05       Impact factor: 91.245

5.  Ecallantide for the acute treatment of angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter, randomized, controlled trial.

Authors:  Lawrence M Lewis; Charles Graffeo; Pascal Crosley; Howard A Klausner; Carol L Clark; Anthony Frank; James Miner; Ryan Iarrobino; Yung Chyung
Journal:  Ann Emerg Med       Date:  2014-08-30       Impact factor: 5.721

6.  Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema.

Authors:  Guillaume Pare; Michiaki Kubo; James B Byrd; Catherine A McCarty; Alencia Woodard-Grice; Koon K Teo; Sonia S Anand; Rebecca L Zuvich; Yuki Bradford; Stephanie Ross; Yusuke Nakamura; Marylyn Ritchie; Nancy J Brown
Journal:  Pharmacogenet Genomics       Date:  2013-09       Impact factor: 2.089

7.  Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema.

Authors:  Brittany T Straka; Claudia E Ramirez; James B Byrd; Elizabeth Stone; Alencia Woodard-Grice; Hui Nian; Chang Yu; Aleena Banerji; Nancy J Brown
Journal:  J Allergy Clin Immunol       Date:  2016-11-29       Impact factor: 10.793

8.  Randomized Trial of Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Upper Airway Angioedema.

Authors:  Richard Sinert; Phillip Levy; Jonathan A Bernstein; Richard Body; Marco L A Sivilotti; Joseph Moellman; Jennifer Schranz; Jovanna Baptista; Alan Kimura; Wolfram Nothaft
Journal:  J Allergy Clin Immunol Pract       Date:  2017-05-25

9.  High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency.

Authors:  C Suffritti; A Zanichelli; L Maggioni; E Bonanni; M Cugno; M Cicardi
Journal:  Clin Exp Allergy       Date:  2014-12       Impact factor: 5.018
  9 in total
  5 in total

1.  Possible donor-dependent differences in efficacy of fresh frozen plasma for treatment of ACE inhibitor-induced angioedema.

Authors:  Sara X Chen; Daniela Hermelin; Steven J Weintraub
Journal:  J Allergy Clin Immunol Pract       Date:  2019-03-02

2.  A Forgotten Cause of Allergy at ER That Is Still Difficult to Diagnose and Treat at Poor Resource Setting: Angioedema after Using Angiotensin Converting Enzyme Inhibitors for 4 Years.

Authors:  A A Nilanga Nishad; K Arulmoly; S A S Priyankara; P K Abeysundara
Journal:  Case Reports Immunol       Date:  2019-01-02

3.  Picomolar Sensitivity Analysis of Multiple Bradykinin-Related Peptides in the Blood Plasma of Patients With Hereditary Angioedema in Remission: A Pilot Study.

Authors:  François Marceau; Georges-Etienne Rivard; Jacques Hébert; Julie Gauthier; Hélène Bachelard; Tanja Gangnus; Bjoern B Burckhardt
Journal:  Front Allergy       Date:  2022-02-11

4.  Genetic susceptibility to angiotensin-converting enzyme-inhibitor induced angioedema: A systematic review and evaluation of methodological approaches.

Authors:  Haivin Aziz Ali; Anne Fog Lomholt; Seyed Hamidreza Mahmoudpour; Thorbjørn Hermanrud; Anette Bygum; Christian von Buchwald; Marianne Antonius Jakobsen; Eva Rye Rasmussen
Journal:  PLoS One       Date:  2019-11-11       Impact factor: 3.240

5.  Angioedema without wheals: a clinical update.

Authors:  Okan Gülbahar
Journal:  Balkan Med J       Date:  2021-03       Impact factor: 2.021
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.